ResearchNet - RechercheNet

• Search Again

• Back to Results

• Print Preview Opens in a new window

• Watch this Opportunity

• Notify a Colleague

Funding Opportunity Details

Funding Organization Canadian Institutes of Health Research Program Name Catalyst Grant
:

        Digital Health **Sponsor(s)** Canadian Institutes of Health Research – Institute of Musculoskeletal Health and Arthritis

Program Launch Date 2025-07-29

Important Dates

| Competition | 202603DIH |
| --- | --- |
| Registration Deadline | 2025-12-16 |
| Application Deadline | 2026-03-17 |
| Anticipated Notice of Decision | 2026-08-20 |
| Funding Start Date | 2026-07-01 |

---

Notices

CIHR will be hosting webinar(s) to support participants with the requirements of this funding opportunity and to answer questions. To find out more information and to register, visit the Webinars page.

---

Table of Contents

• Description
• Objectives
• Eligibility
• Guidelines
• Review Process and Evaluation
• How to Apply
• Contact Information
• Sponsor Description

---

Description

This funding opportunity will catalyze discovery in digital health, advance pivotal research, and inform applications or interventions relevant to CIHR-IMHA's broad mandate areas. This funding opportunity also seeks to benefit the continued integration of technology into healthcare in Canada. These grants are reserved for early and mid-career researchers, and Indigenous Health researchers at any career stage. Patient and/or community engagement as an essential evaluation criterion for these grants, and inclusion of a Knowledge User or Patient Partner as a Principal Applicant or Co-applicant aligns with the Knowledge to Action Framework.

The CIHR-IMHA mandate includes: active living, mobility and the wide range of conditions related to bones, joints, muscles, connective tissue, skin as well as the mouth, teeth and craniofacial region. Digital health research that pertains to these research areas under the CIHR-IMHA mandate includes: SMART devices, wearables, internet of things, remote patient monitoring, clinical application of machine learning, virtual appointments, and addressing the health needs of those who live in remote and rural areas, including the northern regions, particularly given the known geographical health disparities in Canada. The development and scale-up of these tools and services has the potential to address well-established gaps in provision of care and can enhance access to, and efficiency of, healthcare services; strengthen patient-centered care including through greater health literacy relating to personal health data; and better mobilize knowledge between and among researchers, healthcare providers, patients and other knowledge users.

This funding opportunity supports the CIHR 2021-31 Strategic Plan Priority E: Integrate Evidence in Health Decisions, as a research investment that could support the mobilization of health system innovations including in technology, virtual care and artificial intelligence, and aligns with all three of the strategies under this priority. To support CIHR's Strategic Plan, CIHR-IMHA's will invest in digital health research that has the potential for immediate-to-medium term health impact (2-10 years). CIHR-IMHA is also committed to maintaining a focus on equity issues in this research area, specifically the assumption that clinical digital health (telehealth services) improves access.

CIHR and CIHR-IMHA support a research environment that reflects the principles of equity, diversity and inclusion (EDI). We are committed to reconciliation by strengthening the health and well-being of First Nations, Inuit and Métis Peoples. Achieving a more equitable, diverse, and inclusive Canadian research enterprise is essential in creating the excellent, innovative, and impactful research necessary to advance knowledge and understanding, and to respond to local, national, and global challenges. Beyond efforts to bolster EDI, CIHR recognizes that First Nations, Métis, and Inuit are rights-holding as First Peoples of Canada, and initiatives should be developed through distinctions-based approaches, as found in the CIHR strategic plan Setting new directions to support Indigenous research and research training in Canada 2019-2022. Applicants are required to ensure equitable access of diverse researchers, including First Nations, Inuit and Métis, to opportunities available within the research teams that will be established with program funding. This includes ensuring the research environment is supportive and any systemic barriers are addressed effectively and swiftly (see the Best Practices in Equity, Diversity and Inclusion in Research for guidance and examples of systemic barriers).

Role and Contributions of Applicant Partners: CIHR recognizes that a broad range of partners may be relevant to this opportunity and it is expected that applicant(s) describe the role of all applicant partners and how/if they will contribute to research and research related activities. Any consideration of risk and/or conflict of interest should also be explained, as appropriate.

Funds Available

CIHR and partner(s) financial contributions are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or decrease due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.

• The total amount available for this funding opportunity is $1,000,000, enough to fund approximately ten grants. This amount may increase if additional funding partners participate. The maximum amount per grant is $100,000 per year for up to one (1) year For more information on the appropriate use of funds, refer to Allowable Costs.

Top

---

Objectives

The specific objectives of this funding opportunity are to:

• Support original, high quality research in digital health that has the potential to catalyse future research (e.g. may support securing funding through Project Grant and at other Agencies/Councils), including generation of pilot data, and research into evaluation, scale up, or implementation of a digital health product, platform or application.
• Incentivize research that focuses on digital health solutions for the CIHR-IMHA mandate areas.
• Foster a community of CIHR-IMHA digital health researchers that partner with Canadian leaders in equitable digital science.
• Provide research leadership, stimulate innovative research and practice, and strengthen research capacity by dedicating funds to early and mid-career researchers as part of CIHR-IMHA's commitment to Nurture Leaders.
• Strengthen health research by embedding patient and/or community engagement in the funding opportunity.

Top

---

Eligibility

Eligibility to Apply

For an application to be eligible, all the requirements stated below must be met:

1. The Nominated Principal Applicant (NPA) must be:
   • An early or mid-career independent researcher, or a knowledge user, affiliated with a Canadian postsecondary institution and/or its affiliated institutions (including hospitals, research institutes and other non-profit organizations with a mandate for health research and/or knowledge translation); OR
   • A Principal Knowledge User (PKU) who identifies as a patient partner at any career stage. OR
   • An individual of any career stage who is affiliated with an Indigenous non-governmental organization in Canada with a research and/or knowledge translation mandate; OR
   • An Indigenous non-governmental organization in Canada with a research and/or knowledge translation mandate.
2. The NPA must have their substantive role in Canada for the duration of the requested grant term.
3. The Institution Paid receives and administers the funds on behalf of the NPA and therefore must be authorized by CIHR before the funds can be released.
4. Any research applications involving Indigenous Peoples  must include at least one Principal Applicant or Co-Applicant who self-identifies as Indigenous (First Nations, Inuit or Métis) and/or provides evidence of having meaningful and culturally safe involvement with Indigenous Peoples (see How to Apply section for more details).
5. With the exception of research related to Indigenous Health, research must be co-led by an Early- or Mid-Career independent researcher and a Principal Knowledge User (PKU) who identifies as Patient Partner (at any career stage);
   • If the NPA is an Early or Mid-Career Researcher, each applicant team must also include at least one (1) PKU of any career stage who identifies as a Patient Partner as Principal Applicant or Co-Applicant
   • If the NPA is a PKU or an organization, each applicant team must also include at least one (1) Early or Mid-Career Researcher as Principal Applicant or Co-Applicant
   • If the NPA is an Indigenous researcher and/or has experience in working with Indigenous peoples, they may be of any career stage and there is no requirement for a patient partner to be co-applicant.
6. The NPA must have completed at least one of the sex and gender-based analysis training modules available online through CIHR-IMHA and submit a Certificate of Completion for each (see How to Apply section).
7. The NPA must have completed all four modules for Patient Engagement available online through the CIHR-IMHA and have submitted their Certificates of Completions (see How to Apply section).
8. A NPA can submit a maximum of one (1) application under this funding opportunity. If the NPA submits more than one (1) application, CIHR will automatically withdraw the last application(s) submitted based on time-stamp of submission.

Note: NPAs applying as an ECR or MCR can identify participants (Principal Applicants and/or Co-Applicants) at other levels of seniority (ECRs, MCRs, Senior Researchers).

Top

---

Guidelines

CIHR and CIHR-IMHA support a research environment that reflects the principles of equity, diversity and inclusion (EDI). We are committed to reconciliation by strengthening the health and well-being of First Nations, Inuit and Métis Peoples. Achieving a more equitable, diverse, and inclusive Canadian research enterprise is essential in creating the excellent, innovative, and impactful research necessary to advance knowledge and understanding, and to respond to local, national, and global challenges.

Beyond efforts to bolster EDI, CIHR recognizes that First Nations, Métis, and Inuit are rights-holding as First Peoples of Canada, and initiatives should be developed through distinctions-based approaches, as found in the CIHR strategic plan Setting new directions to support Indigenous research and research training in Canada 2019-2022. Applicants are required to ensure equitable access of diverse researchers, including First Nations, Inuit and Métis, to opportunities available within the research teams that will be established with program funding. This includes ensuring the research environment is supportive and any systemic barriers are addressed effectively and swiftly (see the Best Practices in Equity, Diversity and Inclusion in Research for guidance and examples of systemic barriers).

General CIHR Policies

Before submitting an application to this funding opportunity, applicants should review the relevant policies and guidelines on the CIHR Funding Policies page, including the CIHR Application Administration Guide – Part 2 General Requirements for Grants and Awards Applications, to ensure understanding of their roles and responsibilities.

Research Security

The Policy on Sensitive Technology Research and Affiliations of Concern (STRAC Policy) is applicable to this funding opportunity. Consult the Tri-agency guidance on the STRAC Policy for more information.

Allowable Costs

Applicants are advised to consult the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Guide on Financial Administration (TAGFA) to determine if an expenditure is an appropriate use of grant funds.

To further clarify, the following expenses are examples of appropriate uses of grant funds, provided they satisfy the principles and pertinent directives of the TAGFA:

• Cost related to compensation for patient partners. See CIHR guidance on Considerations when paying patient partners in research. Compensation means additional payment over and above incidental expenses (e.g. parking or other travel-relates costs). Compensation should not be confused with 'covering expenses' for patient partners.
• Expenditures that respect the culture and traditions of Indigenous peoples, where needed for the meaningful conduct of research. See TCPS 2 (2022) - Chapter 9 Research Involving the First Nations, Inuit and Métis Peoples of Canada and TAGFA Directive on Gifts, Honoraria and Incentives. These include:
  • Costs related to community mobilization and engagement, including culturally relevant promotional items such as, tobacco, cloth, feasting and gift giving for honoring ceremonies, and cash reimbursements (in a method acceptable to the individual or community being reimbursed) to compensate community participation; and
  • Contracts and/or consultant fees for knowledge translation and communication activities for Indigenous Elders, community members, and Indigenous Knowledge Keepers involved in activities related to the Indigenous community.
• Costs related to the translation and preparation of information/material intended for public consumption for the purposes of informing and engaging partners (e.g., website content, information pamphlets, guidelines, promotional and event-related material, etc.). Use of Personal Information

All information is shared in accordance with the Privacy Act. As per the Privacy Act, personal information means information about an identifiable individual that is recorded in any form.

• Personal information submitted during the application process, including but not limited to information provided through applicant CVs, the Tri-agency Self-identification Questionnaire and other application documents required by this funding opportunity, will be made available to select  CIHR personnel with the appropriate training and security clearance and on a need-to-know basis, for the purposes of future program planning and design and evaluation and learning for organizational and program strengthening. In addition, CIHR may share de-identified, aggregated self-identification information with the sponsoring institutes and competition partners, for this purpose. For further information about the Self-identification Questionnaire and the use of personal information, see the Tri-agency Self-identification Questionnaire Frequently Asked Questions.
• For this funding opportunity, select self-identification questionnaire responses will be shared with authorized CIHR personnel to determine eligibility of applicant(s) for designated funding. For relevant details, refer to Eligibility and Review Process and Evaluation.
• The following information submitted to CIHR at the registration stage will be shared with the proposed institution paid for planning purposes: name of the NPA (and other applicants, if provided), application number, title of the proposal and requested budget.
• For this funding opportunity, some sections of the application containing information that directly or indirectly identifies the applicant(s), will be shared with some funding partner(s) and/or CIHR Institute staff, to assist with relevance review and funding decisions.
• Personal information, including related research security forms, collected as part of the implementation of the research security measures, may be shared with Canada's national security departments and agencies for the purpose of assessing risks to national security. Conditions of Funding

In addition to the general conditions of funding governing CIHR grants, the following are the program specific conditions of funding applicable to this funding opportunity:

• Data related to First Nations, Inuit or Métis communities whose traditional and ancestral territories are in Canada must be managed in accordance with data management principles developed and approved by those communities, and on the basis of free, prior and informed consent. This includes, but is not limited to, considerations of Indigenous data sovereignty, as well as data collection, ownership, protection, use, and sharing.
• All information intended for public consumption, including for the purposes of informing and engaging partners (e.g., website content, information pamphlets, guidelines, promotional and event-related material, etc.), must be provided in both official languages (English and French), accessible to screen readers, and should be developed using plain language practices. See Allowable Costs for more details.
• CIHR is a signatory to the World Health Organization's Joint Statement on Public Disclosure of Results from Clinical Trials ("WHO Joint Statement") requiring all clinical trials to be registered and the results disclosed publicly in a timely manner. For more information, please consult the CIHR Policy Guide - Requirements for Registration and Disclosure of Results from Clinical Trials.
• CIHR reserves the right to terminate or suspend funding if there is a determination of unacceptable national security risk by the Government of Canada.
• Nominated Principal Applicant (NPA) is responsible for the following reporting requirements:
  • Electronic Final Report. This online report will be made available to the NPA on ResearchNet at the beginning of the grant funding period and can be filled in as the research progresses.
• The Principal Applicants who are successful in this competition are strongly encouraged to actively participate in peer review, and as members of the CIHR College of Reviewers, when invited.

Top

---

Review Process and Evaluation

Relevance Review Process

CIHR-IMHA will perform a relevance review at the Full Application stage to identify applications that are in alignment with the objectives of this funding opportunity, as well as relevant to the CIHR-IMHA mandate. Note that digital health is defined broadly to include: SMART devices, wearables, internet of things, remote patient monitoring, clinical application of machine learning, virtual appointments (telehealth, telerehabilitation), and addressing the health needs of those who live in remote and rural areas. These examples of digital health are not exhaustive and applicants are invited to outline how their research falls under the broad digital health umbrella.

Relevance review will be completed based on the one-page Summary of Research Proposal

The following criteria will be used in conducting the relevance review:

• Relevance to the CIHR-IMHA mandate; and
• Relevance or applications of digital health; and
• Alignment with the funding opportunity objectives. Applications that are not deemed to be relevant will be withdrawn from the competition.

Review Process

For information on the peer review process for this funding opportunity, see the Review guidelines for priority-driven initiatives.

For information on CIHR's peer review principles, see the Peer Review: Overview section of CIHR's website.

Peer review will be conducted in accordance with the San Francisco Declaration on Research Assessment (DORA).

Evaluation Criteria

To support the strategic objectives of this funding opportunity, the following evaluation criteria will be used:

1. Research Approach
   1. Extent to which the project responds to the objectives of the funding opportunity.
   2. Strength, feasibility and appropriateness of the proposed research design and methodology (including recruitment, project timeline, preliminary data where appropriate, etc.).
   3. Quality and appropriateness of integration of intersecting considerations such as biological variables (e.g., sex, age) and the impacts of inequalities and discrimination based on Indigeneity, socio-economic status, disability, sexual orientation, gender, racism, culture, and/or language as applicable, in the research plan.
   4. For applications submitted by early and mid-career investigators, the following criteria will also be evaluated:
   5. The quality and appropriateness of a patient engagement plan for their research project or program, and extent to which this demonstrates adherence to the Strategy for Patient-Oriented Research Patient Engagement Framework four guiding principles: inclusiveness, support, mutual respect and co-build with respect to working with patient partners.
   6. A letter of support from an end user (patient, hospital, health provider, health authority, government, charity, or other) to speak to the relevance of the proposed digital health research to any of a broad range of end users.
   7. For research projects involving First Nations, Inuit, and/or Métis Peoples, the following criteria will also be considered:
   8. Appropriateness of the description of how the team will address research conducted by, grounded in, or engaged with First Nations, Inuit or Métis communities, societies or individuals and their wisdom, cultures, experiences or knowledge systems, as expressed in their dynamic forms, past and present.
   9. The research project must demonstrate appropriate consideration of TCPS 2 – Chapter 9: Research Involving the First Nations, Inuit and Métis Peoples of Canada, and meaningful and culturally safe practices, plans and activities throughout the research project.
2. Originality of the Proposal
   1. The research gap is well defined and a clear rationale is provided for how the proposed work would meet this gap.
   2. The innovation of the proposal (for example regarding disease, relevant population, novel methods or technology, and treatment or intervention) is demonstrated.
3. Applicant(s)
   1. Appropriateness of the Nominated Principal Applicant as a researcher or knowledge user with proven expertise, relative to career stage, in the identified research area and with the proposed methodology/ies.
4. Environment for the Research
   1. Demonstration of the availability and accessibility of personnel, facilities and infrastructure required to conduct the research.
5. Impact of the Research
   1. Extent of the role(s) and contribution(s) of all applicant partner(s) in advancing research objectives (if applicable).
   2. Proactive and meaningful consideration of partnership risks, including the extent of real and/or perceived conflict of interest and appropriateness of its management and mitigation (if applicable).
   3. Potential for a significant contribution related to the objectives of this funding opportunity. Funding Decision

Applications will be funded from the top down in order of ranking. Applications that receive a rating below 3.5 will not be funded.

The names of successfully funded applicants will be published on the CIHR website.

Partner and Internal Collaborator Participation

The opportunity to add new partners and internal collaborators to this funding opportunity may arise after publication. These partners and internal collaborators may not be listed; however, the principles that govern relevance review, including consent to share information and funding decisions, will still apply.

Top

---

How to Apply

• The application process for this funding opportunity is comprised of two steps: Registration and Full Application
• To complete your Registration, follow the instructions in the Grants – Registration Guidelines, along with any additional instructions found below under "Specific Instructions". Note that a Registration must be submitted to be eligible to submit a full application.
• To complete your Full Application, follow the "Specific Instructions" listed below, and where applicable, consult the Grants – Application Guidelines.
• All participants listed, with the exception of Collaborators and Patient Partners, are required to:
  • Have/obtain a CIHR PIN
  • Complete the Tri-Agency Self-identification Questionnaire.
  • Organizations applying as Nominated Principal Applicants for the first time must contact CIHR's Contact Centre for guidance in creating a ResearchNet account and registering for a CIHR PIN. Specific instructions to complete your ResearchNet application

Step 1 — Registration

Task: Identify Participants

• List the Nominated Principal Applicant (NPA) and the Principal Applicants (optional) in the "Identify Participants" task.
• The Nominated Principal Applicant (NPA) must remain unchanged between the registration and full application phases of the competition. The Principal Applicants can be added or removed between the two stages.
• CV not required at this stage.

• It is recommended that the NPA actively support Patient Partners with all relevant application requirements.
  Task: Complete Summary of Research Proposal

• Summarize your research proposal, including how your participation in this initiative would achieve the objectives of this funding opportunity. Note that your summary cannot exceed one (1) page.

• Please note that this will be the only document used for relevance review. Additionally, the summary may be used to find reviewers with the expertise required to assess the Full Application.
  Task: Complete Peer Review Administration Information (Optional)

• Suggest reviewers that have the expertise to review your application. You should not suggest reviewers in conflict of interest. Consult the Conflict of Interest and Confidentiality Agreement for Peer Reviewers and Peer Review Observers on the CIHR website for more information. CIHR reserves the right to make the final selection of reviewers.
  Task: Manage Access (optional)

• The Nominated Principal Applicant (NPA) can delegate access to a maximum of five individuals to support the completion of the application. Note: A delegate's access does not carry over from one stage of the competition to another (i.e., from the registration to the application stage). The NPA will need to delegate access at each stage of a competition. NPAs should revoke delegates' access prior to completing the Consent and Submit tasks if they do not want them to retain access to submitted applications via their Completed Activities tab. For more information, please see the Frequently Asked Questions (FAQ).
  Step 2 — Application

Task: Identify Participants

• List all participants in the "Identify Participants" task. Consult the Eligibility section and ensure that all requirements are met. Ensure that all are listed in the Participants table.

• All participants are required to submit a CV (excluding collaborators).

  • All academic applicants, working/residing in Canada, are required to upload a CIHR Biosketch CV.
  • Knowledge users, non-academics, Indigenous organizations, and international applicants have the option to submit either a CIHR Biosketch CV or Applicant Profile CV (maximum three pages per applicant).
  • NPA categories involving an Indigenous non-governmental organization as an eligibility requirement must include in their Applicant Profile CV, a description of the organization and how it meets the eligibility requirement of being an Indigenous non-governmental organization with a research or knowledge mobilization mandate.
  • Submit Biosketch CVs using the Canadian Common CV (CCV) interface. Submit Applicant Profile CVs by uploading the completed document, in the "Attachment" tab. Task: Enter Proposal Information

• The Research Proposal must address the objectives of the funding opportunity and the specific evaluation criteria.

• Research proposals written in French will be allowed to submit additional pages, in support of evidence demonstrating that French documents require approximately 20% more space than similar English documents. Therefore, to ensure an equitable amount of space is provided, the following page limits will apply:

  • 5 pages for Research Proposals written in English
  • 6 pages for Research Proposals written in French Note: Any additional pages over the above-mentioned limit will be removed with no further notification to the Nominated Principal Applicant.

• This section must not include reference list, charts, tables, figures, and photographs. Attach any documents supporting the proposal (e.g., reference list, charts, tables, figures, photographs, etc.) in the "Attachments – Research Proposal Appendix" (optional).
  Task: Identify Sensitive Technology Research Areas

• If the research grant will aim to advance any of the listed Sensitive Technology Research Areas, the applicant must answer "Yes" to the screening question.

• All researchers with named roles in the research grant must review the List of Named Research Organizations, and are individually required to complete the Attestation form.

• The NPA must combine all attestation forms into one (1) PDF file and upload it under this task.

• Completed attestation forms will be neither accessible to, nor shared with, peer reviewers.

• CIHR will use this information to ensure applicants are compliant with the Government of Canada's policy on Sensitive Technology Research and Affiliations of Concern.

• For resources to assist in completing the Attestation form, please consult the Sensitive Technology Research and Affiliations of Concern, the Tri-agency guidance on the Policy on Sensitive Technology Research and Affiliations of Concern (STRAC Policy); and CIHR Research Security.
  Task: Complete Summary of Research Proposal

• Summarize your research proposal, including how your participation in this initiative would achieve the objectives of this funding opportunity. Note that your summary cannot exceed one (1) page.

• Please note that this will be the only document used for relevance review. Additionally, the summary may be used to find reviewers with the expertise required to assess the Full Application.
  Task: Enter Budget Information

• Provide a detailed budget justification in relation to planned activities and clearly justify all budget items (including cash and cash equivalent contributions, if relevant).

• Upload Release Time Allowance request under "Other Supporting Documents". For Release Time Allowance requests, you must include a letter from the recipient's organization certifying that the individual for whom the Release Time Allowance is requested:

  • Is a knowledge user on the grant whose primary responsibilities do not include an expectation to engage in research (i.e., as part of their regular employment);
  • Has their organization's approval for the research time on the project that would justify the allowance; and
  • Is engaged in the activities for which funds are being disbursed. Task: Attach Other Application Materials

• Other – attach the following under "Other":

  • Label as 'SGBA+ Certificate – Name' (mandatory for NPA): Certificate of Completion for the Sex- and gender-based analysis training modules (attach an unsecured version).
  • After completing the appropriate training module that applies to your research project, you will receive a certificate of completion that you will save and upload here. The training module should take approximately 40 minutes to complete.
  • N.B. The certificate was previously issued as a secured document. If your certificate is secured, to successfully append the document to your application, you must upload an unsecured PDF copy. The certificate can be saved as an unsecured PDF by using print screen or by scanning the document.
  • Label as 'Patient Engagement in Research Resources Certificate' (mandatory for the NPA): Certificates of Completion of the four (4) Patient Engagement Training modules (please attach an unsecured version) must be submitted with the application for the NPA.
  • Each certificate is issued as a secured document; however, you must upload a copy of the certificate (e.g., print screen) as an unsecured PDF file in order to successfully append the document. Scanned documents and photocopies are acceptable.
    • Each certificate should be labeled with the first initial and last name of the NPA followed by "ModuleNumber_Certificate".
  • Other participants are highly encouraged to take all four (4) of the Patient Engagement in Research training modules, including patient partners.
    • The certificates of completion are not mandatory for other participants (excluding the NPA), but it is highly encouraged that they take the first two (2) training modules and submit the Certificates of Completion under "Other" using the same labeling as specified above.
  • Applicant Partner COI Document (required if applicable): Describe the role of all applicant partners, how/if they will contribute to research and research related activities, and any consideration of risk and/or conflict of interest as appropriate (maximum one page).
  • Label as "Indigenous Health Research" (required if applicable): Applications related to the Indigenous Health Research must include at least one applicant who self-identifies as Indigenous (First Nations, Inuit, or Métis) and/or demonstrates a track record of meaningful and culturally safe involvement with Indigenous Peoples. Complete and submit the Indigenous Health Research Cultural Safety Form.
  • Patient Engagement Plan – upload as 'Patient Engagement Plan' (for ECR/MCR applicants)
  • Description of how the research project will integrate meaningful patient engagement approaches and adhere to the Strategy for Patient-Oriented Research Patient Engagement Framework four guiding principles: inclusiveness, support, mutual respect and co-build with respect to working with patient partners.

• Participant Table – upload as "Participant Table" (mandatory): This table will be used for eligibility assessment. In a table format with column headers matching the bolded titles below, provide the following information about all applicant team members (including Collaborators):

  • Name (Last Name, First Name or organization);
  • Role of participant (e.g., Nominated Principal Applicant, Principal Applicant, Co-Applicant, Knowledge User, Collaborator);
  • Primary affiliation, host institution/organization of each participant, where appropriate (note this may be included for Knowledge Users including Patient Partners but is not required);
  • Participant type(s) (e.g., researcher [Early-, Mid-, or Senior Career Researcher, trainee], patient partner, knowledge user, participant who self-identifies as Indigenous (First Nations, Métis or Inuit) or provides evidence of having meaningful and culturally safe involvement with Indigenous communities, participant affiliated with a First Nations, Inuit or Métis  community or organization, Indigenous organization, Indigenous Elder or Knowledge Keeper;
  • When completing the application, applicants must protect the privacy and confidentiality of all team members. How an individual self-identifies is personal and confidential information, which should not be disclosed without consent

• Letters of Support – upload as 'Letter of Support' (for all applicants)

  • A letter of support from an end user (patient, hospital, health provider, health authority, government, charity, or other) to speak to the relevance of the proposed digital health research to any of a broad range of end users. Please refer to the CIHR examples of details to be provided in letters of support.

• Publication List (optional) – Upload under "Publications":

  • List a maximum of three (3) publication citations relevant to the proposal. Note: Any pages over the page limits specified for attachments under "Other" will result in the removal of additional pages with no further notification to the Nominated Principal Applicant. Task: Complete Peer Review Administration Information (Optional)

• Suggest reviewers that have the expertise to review your application. You should not suggest reviewers in conflict of interest. Consult the Conflict of Interest and Confidentiality Agreement for Peer Reviewers and Peer Review Observers on the CIHR website for more information. CIHR reserves the right to make the final selection of reviewers.
  Task: Manage Access (optional)

• The Nominated Principal Applicant (NPA) can delegate access to a maximum of five individuals to support the completion of the application. Note: A delegate's access does not carry over from one stage of the competition to another (i.e., from the registration to the application stage). The NPA will need to delegate access at each stage of a competition. NPAs should revoke delegates' access prior to completing the Consent and Submit tasks if they do not want them to retain access to submitted applications via their Completed Activities tab. For more information, please see the Frequently Asked Questions (FAQ).
  Task: Print Signature Page

• Signature Requirements:

  • Signature of the Nominated Principal Applicant is not required for applications submitted through ResearchNet.
  • Signatures must be included for all other applicants (except Collaborators), and individual(s) with signing authority from the Institution Paid.
  • Original signatures are not required. The scanned signed signature pages and the Routing Slip must be uploaded in the Print/Upload Signature Pages task in ResearchNet prior to submitting your application.

Top

---

Contact Information

For all inquiries, please contact:

CIHR Contact Centre
Telephone: 613-954-1968
Toll Free: 1-888-603-4178
Email: support-soutien@cihr-irsc.gc.ca

For service hours, please consult our CIHR Contact Centre page.

Top

---

Sponsor Description

Partners

Note: Additional partners/internal collaborators, including from industry and the private sector, may join this funding initiative over the coming year.

Internal Collaborators

Canadian Institutes of Health Research
At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada's health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.

CIHR – Institute of Musculoskeletal Health and Arthritis (IMHA)
IMHA is the hub for strategic initiatives in musculoskeletal (MSK), skin and oral health research in Canada. IMHA's mandate is to support ethical and impactful research to enhance active living, mobility and oral health, and to address the wide range of conditions related to bones, joints, muscles, connective tissue, skin and teeth. Musculoskeletal health is critical for promoting the physical activity needed to maintain mobility, productivity and general health and well-being. Prevalent MSK disorders, such as arthritis and osteoporosis, can limit mobility and physical activity, creating a vicious cycle of inactivity, degeneration and loss of productivity. Similarly, poor oral health and skin conditions can affect overall health and well-being.

Top

• Search Again

• Back to Results

• Print Preview Opens in a new window

• Watch this Opportunity

• Notify a Colleague
  Date Modified:

20260226.1